1 – 10 of 30
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
CYLD controls c-MYC expression through the JNK-dependent signaling pathway in hepatocellular carcinoma.
(
- Contribution to journal › Article
- 2013
-
Mark
CYLD Enhances Severe Listeriosis by Impairing IL-6/STAT3-Dependent Fibrin Production
(
- Contribution to journal › Article
- 2012
-
Mark
A20 and CYLD Do Not Share Significant Overlapping Functions during B Cell Development and Activation
(
- Contribution to journal › Article
- 2011
-
Mark
The E3 ligase Itch and deubiquitinase Cyld act together to regulate Tak1 and inflammation
(
- Contribution to journal › Article
-
Mark
Caspase 8 inhibits programmed necrosis by processing CYLD
(
- Contribution to journal › Article
-
Mark
CYLD: a deubiquitination enzyme with multiple roles in cancer.
(
- Contribution to journal › Article
- 2010
-
Mark
CYLD negatively regulates cell-cycle progression by inactivating HDAC6 and increasing the levels of acetylated tubulin
(
- Contribution to journal › Article
-
Mark
Persistent NFkappaB activation in malignant melanoma is generated through loss of the tumor suppressor CYLD
2010) 33rd Annual Meeting of the German-Society-for-Cell-Biology/German Melanoma Research Network In European Journal of Cell Biology 89. p.1-1(
- Contribution to journal › Published meeting abstract
-
Mark
Cyld: A Key Regulator Of Hepatocellular Apoptosis, Proliferation And Carcinogenesis
2010) 45th Annual Meeting of the European-Association-for-the-Study-of-Liver- In Journal of Hepatology 52. p.32-33(
- Contribution to journal › Published meeting abstract
-
Mark
Persistent NFkappaB activation in malignant melanoma is generated through loss of the tumor suppressor CYLD
2010) 37th Annual Meeting of the Arbeitsgemeinschaft-Dermatologishche-Forschung In Experimental Dermatology 19(2). p.209-209(
- Contribution to journal › Published meeting abstract